Literature DB >> 22732356

Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls.

Luís Costa-Matos1, Paulo Batista, Nuno Monteiro, Maria Simões, Conceição Egas, Jorge Pereira, Helena Pinho, Natália Santos, João Ribeiro, Maria A Cipriano, Pedro Henriques, Fernando Girão, Alfredo Rodrigues, Armando Carvalho.   

Abstract

BACKGROUND AND AIMS: Hepcidin plays a crucial role in iron metabolism, preventing its absorption at the basolateral enterocyte membrane. Hepcidin regulation is complex and regulated at the transcriptional level. The relation between iron overload and alcoholic liver disease is well known, but its mechanism is not clear. We present an observational, case-control study, aimed at evaluating the effects of alcohol on the expression of hepcidin in human participants. We intended to assess whether iron overload related to alcohol ingestion was caused by hepcidin-impaired expression by determining hepcidin mRNA expression and relating it to iron stores, both in alcoholic patients and in normal controls.
METHODS: We compared liver hepcidin mRNA expression between 25 active drinkers with alcoholic liver disease, without cirrhosis, and 20 healthy controls. All individuals were evaluated for HFE mutations, complete blood count, coagulation, glucose, kidney function, liver function, viral hepatitis, C-reactive protein, interleukin 6, tumor necrosis factor α, and serum iron, ferritin, and transferrin saturation. Total RNA was isolated from liver samples, cDNA was obtained by reverse transcription, and hepatic expression levels of hepcidin were determined by real-time PCR using the comparative Ct method (2(-ΔΔCt)).
RESULTS: Serum ferritin and transferrin saturation were significantly higher in patients. Hepcidin was downregulated in patients compared with the controls by a mean factor of -0.44 (log10 2(-ΔΔCt)) (P=0.009). Hepcidin expression was not significantly different between the several grades of fibrosis, necroinflammatory activity, and liver iron stores. Heavy alcohol consumption caused the highest hepcidin mRNA suppression. The hepcidin mRNA expression/serum ferritin ratio was significantly lower in alcoholic patients (P<0.0001).
CONCLUSION: Hepcidin liver expression is inappropriately low in alcoholic patients with active alcoholism and preserved hepatic function, and we conclude that this is the mechanism for alcohol consumption-associated iron overload in humans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22732356     DOI: 10.1097/MEG.0b013e328355cfd0

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  19 in total

1.  A male patient with ferroportin disease B and a female patient with iron overload similar to ferroportin disease B.

Authors:  Tetsuji Yamashita; Natsuko Morotomi; Tetsuro Sohda; Hisao Hayashi; Naohiko Yoshida; Keiko Ochi; Izumi Ohkura; Mika Karita; Hiroko Fujiwara; Haruhiko Yamashita; Ai Hattori; Yasuaki Tatsumi
Journal:  Clin J Gastroenterol       Date:  2014-04-19

Review 2.  New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases.

Authors:  Jessica A Williams; Sharon Manley; Wen-Xing Ding
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

3.  Effects of Averrhoa carambola L. (Oxalidaceae) juice mediated on hyperglycemia, hyperlipidemia, and its influence on regulatory protein expression in the injured kidneys of streptozotocin-induced diabetic mice.

Authors:  Hoa Thi Thai Pham; Wansu Huang; Chuangye Han; Juman Li; Qiuqiao Xie; Jinbin Wei; Xiaohui Xu; Zefeng Lai; Xiang Huang; Renbin Huang; Qingwei Wen
Journal:  Am J Transl Res       Date:  2017-01-15       Impact factor: 4.060

Review 4.  Iron and iron-related proteins in alcohol consumers: cellular and clinical aspects.

Authors:  Kevin Ferrao; Najma Ali; Kosha J Mehta
Journal:  J Mol Med (Berl)       Date:  2022-10-10       Impact factor: 5.606

5.  Iron deficiency in patients with nonalcoholic Fatty liver disease is associated with obesity, female gender, and low serum hepcidin.

Authors:  Asma Siddique; James E Nelson; Bradley Aouizerat; Matthew M Yeh; Kris V Kowdley
Journal:  Clin Gastroenterol Hepatol       Date:  2013-11-20       Impact factor: 11.382

6.  Alcohol's Dysregulation of Maternal-Fetal IL-6 and p-STAT3 Is a Function of Maternal Iron Status.

Authors:  Nipun Saini; Kaylee K Helfrich; Sze Ting Cecilia Kwan; Shane M Huebner; Juna Abazi; George R Flentke; Sharon E Blohowiak; Pamela J Kling; Susan M Smith
Journal:  Alcohol Clin Exp Res       Date:  2019-10-08       Impact factor: 3.455

7.  DNA methylation and gene expression profiles show novel regulatory pathways in hepatocellular carcinoma.

Authors:  Silvia Udali; Patrizia Guarini; Andrea Ruzzenente; Alberto Ferrarini; Alfredo Guglielmi; Valentina Lotto; Paola Tononi; Patrizia Pattini; Sara Moruzzi; Tommaso Campagnaro; Simone Conci; Oliviero Olivieri; Roberto Corrocher; Massimo Delledonne; Sang-Woon Choi; Simonetta Friso
Journal:  Clin Epigenetics       Date:  2015-04-14       Impact factor: 6.551

8.  Effects of Chinese Medicine Tong xinluo on Diabetic Nephropathy via Inhibiting TGF- β 1-Induced Epithelial-to-Mesenchymal Transition.

Authors:  Na Zhang; Yanbin Gao; Dawei Zou; Jinyang Wang; Jiaoyang Li; Shengnan Zhou; Zhiyao Zhu; Xuan Zhao; Liping Xu; Haiyan Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-17       Impact factor: 2.629

9.  Hepatic iron in African Americans who underwent liver biopsy.

Authors:  James C Barton; Luigi F Bertoli; Thomas J Alford; J Clayborn Barton; Corwin Q Edwards
Journal:  Am J Med Sci       Date:  2015-01       Impact factor: 2.378

10.  Inhibiting heme oxygenase-1 attenuates rat liver fibrosis by removing iron accumulation.

Authors:  Qiu-Ming Wang; Jian-Ling Du; Zhi-Jun Duan; Shi-Bin Guo; Xiao-Yu Sun; Zhen Liu
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.